z-logo
open-access-imgOpen Access
Elimination Pathways of Fusion Protein and Peptide Drugs
Publication year - 2020
Publication title -
biointerface research in applied chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 11
ISSN - 2069-5837
DOI - 10.33263/briac112.91399147
Subject(s) - fusion protein , fusion , function (biology) , peptide , computational biology , chemistry , biochemistry , microbiology and biotechnology , biology , recombinant dna , gene , linguistics , philosophy
Fusion proteins have been known as an interesting subject for scientific researches in improving properties or making a new function by synergistically incorporating two protein domains into one complex. Fusion proteins are created by ligation of two or more protein domains in a single polypeptide with functional properties. Improvement of therapeutic function is one of the main goals for developing these products. Elimination from the body is one of the most important points that should be considered in the design and production of fusion proteins. This review describes some of the most important excretion/elimination pathways of fusion peptide and protein drugs as well as serious elimination challenges in the development and manufacturing of fusion proteins.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here